Health
Medical Breakthrough: Low-Cost Antidepressant Found to Combat Long COVID Fatigue
Researchers find that the low-cost antidepressant fluvoxamine significantly reduces fatigue in long COVID patients, offering a major breakthrough for millions.

A Major Advance in Long COVID Treatment
A global research team co-led by McMaster University has announced a significant breakthrough in the treatment of long COVID, identifying one of the first medications proven to meaningfully reduce persistent fatigue. According to a randomized, placebo-controlled clinical trial published in the Annals of Internal Medicine, the widely available antidepressant fluvoxamine significantly improved both energy levels and the overall quality of life for patients struggling with the long-term effects of the virus.
Fatigue remains the most debilitating symptom for the estimated 65 million people living with long COVID worldwide. For many, the exhaustion is so profound that it prevents them from returning to work or engaging in daily family activities. Despite the scale of the crisis, medical guidelines have largely been limited to supportive care and pacing due to a lack of evidence-based pharmacological options.
The REVIVE-TOGETHER Trial Results
The study, known as the REVIVE-TOGETHER trial, involved 399 adults in Brazil who had experienced persistent fatigue for at least 90 days following a COVID-19 infection. Participants were randomly assigned to receive either fluvoxamine, the diabetes medication metformin, or a placebo for 60 days. The results were stark: researchers found a 99 percent probability that fluvoxamine outperformed the placebo in reducing fatigue. Conversely, while metformin has previously shown promise in preventing long COVID if taken during the initial infection, it offered no meaningful benefit for those with established fatigue symptoms.
“This is an important step forward for patients who have been desperate for evidence-based options,” said Edward Mills, senior author and professor at McMaster University. He noted that because fluvoxamine is already widely used and well-understood by the medical community, it has immediate potential for clinical application.
Innovation in Clinical Research
Beyond the discovery of the drug’s efficacy, the trial was notable for its sophisticated Bayesian adaptive design. This allowed the international team—comprising researchers from Stanford, UBC, Duke, and several Brazilian institutions—to reach conclusions more efficiently than traditional trials. The study was able to stop specific treatment arms once the evidence became clear, accelerating the delivery of much-needed data to the public.
While experts emphasize that long COVID is a complex condition that may require multiple treatment pathways, the identification of fluvoxamine provides clinicians with the first strong evidence for a medication that targets the condition’s most common symptom. Further research is expected to determine which specific patient profiles benefit most from the treatment.
Health
Canadian Premiers Demand Return to 50/50 Federal Health-Care Funding Split
Canadian premiers in Charlottetown demand Ottawa return to a 50/50 health-care funding split, citing aging populations and economic competitiveness.

Provincial Leaders Push for Historic Funding Model
At a high-stakes summit in Charlottetown, Canada’s provincial leaders have reignited a long-standing battle with the federal government, demanding a return to a 50/50 cost-sharing model for health care. The premiers of Prince Edward Island, New Brunswick, and Manitoba are leading the charge, arguing that the current federal contribution is insufficient to sustain a modernizing and aging health-care system.
Historically, the federal government split health expenses equally with provinces until the 1970s, when the formula was adjusted in favor of tax points and block funding. Today, the Canada Health Transfer (CHT) accounts for roughly 22 per cent of provincial health expenditures. This disparity has become a critical point of friction, as health care now consumes between 30 and 40 per cent of total provincial budgets.
Economic Competitiveness and a National Vision
Manitoba Premier Wab Kinew framed the debate as a matter of national identity and economic strategy. Comparing the Canadian system to that of the United States, Kinew noted that public health care makes Canada a more attractive destination for business investment. “This is one of the reasons why businesses should realize that their investment in Canada is more competitive than putting those dollars to work in the States,” Kinew stated, emphasizing that employers in Canada face lower health-care overheads for their workforce.
P.E.I. Premier Rob Lantz echoed these sentiments, describing the health-care system as a “nation-building project.” For smaller provinces like P.E.I., the focus remains on workforce retention, recruitment, and improving access to primary care, all of which require a more robust and predictable influx of federal cash.
Addressing Chronic Needs and Aging Populations
New Brunswick Premier Susan Holt highlighted the demographic challenges facing her province, which deals with an older population and higher rates of chronic disease than the national average. Holt argued that the CHT must be adapted to recognize these specific needs. “We cannot grow our economy and invest in our defence sector… without that healthy workforce,” Holt said, calling for federal contributions to match those of the provinces.
While Ottawa has signed various 10-year bilateral health-care deals with provinces recently—such as Ontario’s $3.1-billion agreement—the premiers maintain that these localized fixes are no substitute for a fundamental restructuring of the core funding partnership.
Health
Beyond the Caffeine Buzz: How Coffee Harmonizes Your Gut and Brain Health
New research from University College Cork reveals how coffee improves gut bacteria, reduces inflammation, and boosts brain health via the gut-brain axis.
The Powerful Connection Between Your Cup and Your Core
For millions, the morning coffee ritual is a non-negotiable start to the day. However, new research is revealing that the benefits of this global staple extend far beyond a simple energy boost. Recent studies conducted at University College Cork, Ireland, suggest that moderate coffee consumption—specifically three to five cups per day—acts as a catalyst for the ‘microbiota-gut-brain axis,’ a complex communication network linking our digestive system to our mental state.
Cultivating a Healthier Microbiome
The study found that regular coffee drinkers harbor higher levels of beneficial bacteria within their gastrointestinal tracts. These ‘good’ microbes play a critical role in aiding digestion and potentially eliminating harmful stomach infections. Interestingly, these positive shifts in gut health were observed regardless of whether the coffee was caffeinated or decaffeinated. This suggests that the bioactive compounds in the coffee bean itself, such as polyphenols, are the primary drivers of gut health rather than the caffeine content.
Mental Health and the Cognitive Edge
The impact of coffee on the brain is equally multifaceted. Researchers noted distinct benefits depending on the type of brew: caffeinated coffee was linked to reduced anxiety, improved attention, and better stress coping, while decaffeinated coffee showed a stronger correlation with enhanced sleep quality and memory. Both varieties, however, were found to lower levels of depression and systemic inflammation. The presence of the anti-inflammatory cytokine IL-10 in coffee drinkers suggests that the beverage may help neutralize free radicals, potentially lowering the long-term risk of cellular damage and certain cancers.
A Complex Beverage for a Complex System
While coffee can cause a temporary spike in blood pressure, the study reinforces that it does not increase the risk of long-term hypertension in healthy individuals. The most intriguing takeaway is that coffee improves mood independently of cortisol levels, meaning its stress-reducing effects work through unique biological pathways. By supporting the gut microbiome and reducing inflammation, coffee serves as a holistic tool for metabolic and psychological wellness, proving that your daily habit is doing much more than just keeping you awake.
Africa
Deadly Bundibugyo Outbreak in Congo Outpacing Global Response as Deaths Surge
The DRC’s Ebola Bundibugyo outbreak is outpacing global efforts with 220 dead. Lack of vaccines, funding cuts, and conflict create a perfect storm for catastrophe.

A Race Against Time in Ituri
The Democratic Republic of Congo is facing a catastrophic escalation in its latest Ebola outbreak, as health officials warn that the virus is spreading at a \”breakneck speed\” that has already overwhelmed international response efforts. Centered in the volatile Ituri province, the outbreak involves the rare Bundibugyo strain—a variant for which there is currently no approved vaccine or effective medical treatment. According to the World Health Organization (WHO), the crisis has already claimed an estimated 220 lives out of 900 suspected cases, with the virus now confirmed to have crossed the border into neighboring Uganda.
The Critical Gap in Contact Tracing
Leaked documents from a high-level coordination meeting between the WHO and the Africa Centres for Disease Control and Prevention (Africa CDC) reveal a terrifying reality: the response is weeks behind the virus’s trajectory. As of last week, only 7 percent of the over 1,200 identified contacts of suspected patients had been tracked. That number of potential exposures has since risen to more than 2,000, yet the majority remain unmonitored. Experts point out that the virus circulated undetected for six weeks before the first official report, giving it a massive head start in a region already destabilized by conflict.
A Perfect Storm of Funding and Fear
The global health response is struggling under the weight of several systemic failures. The withdrawal of the United States from the WHO and significant cuts to international aid have left a leadership vacuum and a shortage of essential resources, from fuel for transport vehicles to specialized diagnostic tests. Locally, health workers face violent resistance; hospitals have been attacked and isolation units burned by communities wary of outside intervention. This mistrust, coupled with the absence of modern vaccines, has forced medical teams like M decins Sans Fronti res to return to the \”basics\” of containment used decades ago.
Lessons from the Past
Comparison to the devastating 2014-2016 West African epidemic is inevitable. Epidemiologists warn that unless funding and personnel increase immediately, the current situation in the DRC could mirror the tragedy of the past, where fear led families to hide the sick, further fueling the contagion. With healthcare workers already among the casualties, every day without a fully resourced response allows the virus to claim more ground in one of the world’s most vulnerable regions.
-
LOCAL6 days ago
Gordie Howe Bridge: Deciphering the High-Stakes Toll Revenue Deal Between Canada and the U.S.
-
Environment6 days ago
B.C. Wildfire Service Braces for ‘Significant Weather Day’ as Heatwave Peaks
-
POLITICS6 days ago
Section 338 Shockwave: U.S. Hits Canada With 50% Tariffs on 400 Products
-
POLITICS6 days ago
Ezra Levant Pledges Strict Compliance as Tamara Lich Seeks International Travel Rights
-
Health6 days ago
Canadian Premiers Demand Return to 50/50 Federal Health-Care Funding Split
-
CFL6 days ago
BC Lions Scramble for QB Depth: Tyrie Adams Signed Following Nathan Rourke Injury
-
nation6 days ago
Red Deer Ranks Third Highest for Crime in Canadian Metros Amid National Decline
-
Environment23 hours ago
Global Wildfire Crisis: B.C. Faces Intense Week as Smoke and Diplomatic Tensions Rise